HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon BeComing First-Year Direct Sales Targeted At $20 Mil.-$30 Mil.

This article was originally published in The Rose Sheet

Executive Summary

Avon beComing is expected to generate approximately $20 mil.-$30 mil. in its first year in the direct-sell channel, Avon President and Chief Operating Officer Susan Kropf stated in a conference call with analysts Feb. 4

You may also be interested in...



Avon Retinol Technology Debuts In Lip Delux Anti-Aging Lipsticks

Avon will launch beComing Lip Delux Smoothing Retinol Lipcolor in July as the first lipstick on the market to contain active retinol in its formula. The ingredient helps reverse signs of aging in the lip area and restore a healthy, rosy appearance, the firm said

Avon Retinol Technology Debuts In Lip Delux Anti-Aging Lipsticks

Avon will launch beComing Lip Delux Smoothing Retinol Lipcolor in July as the first lipstick on the market to contain active retinol in its formula. The ingredient helps reverse signs of aging in the lip area and restore a healthy, rosy appearance, the firm said

Avon Retail Strategy BeComing Direct-Sell As Penney’s Minimizes Cosmetics

Avon plans to reposition the beComing beauty brand in the U.S. by folding the retail collection into its direct-sell business and ending its partnership with J.C. Penney, which announced it is de-emphasizing cosmetics sales

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel